Log in

NASDAQ:APTOAptose Biosciences News Headlines

$5.80
+0.05 (+0.87 %)
(As of 04/3/2020 04:00 PM ET)
Add
Compare
Today's Range
$5.57
Now: $5.80
$5.94
50-Day Range
$4.74
MA: $6.97
$9.00
52-Week Range
$1.81
Now: $5.80
$9.25
Volume457,000 shs
Average Volume1.06 million shs
Market Capitalization$442.34 million
P/E RatioN/A
Dividend YieldN/A
Beta1.77

Headlines

Aptose Biosciences (NASDAQ APTO) News Headlines

Source:
DateHeadline
Aptose Biosciences Inc. (NASDAQ:APTO) Short Interest Down 5.7% in MarchAptose Biosciences Inc. (NASDAQ:APTO) Short Interest Down 5.7% in March
www.americanbankingnews.com - March 30 at 5:08 AM
 Analysts Expect Aptose Biosciences Inc. (NASDAQ:APTO) to Post -$0.10 EPS Analysts Expect Aptose Biosciences Inc. (NASDAQ:APTO) to Post -$0.10 EPS
www.americanbankingnews.com - March 28 at 11:51 AM
Aptose Biosciences Inc. (NASDAQ:APTO) CEO Buys $19,788.00 in StockAptose Biosciences Inc. (NASDAQ:APTO) CEO Buys $19,788.00 in Stock
www.americanbankingnews.com - March 26 at 4:05 PM
Aptose Biosciences Inc. (NASDAQ:APTO) Given Consensus Rating of "Buy" by BrokeragesAptose Biosciences Inc. (NASDAQ:APTO) Given Consensus Rating of "Buy" by Brokerages
www.americanbankingnews.com - March 24 at 2:56 AM
Bromodomain Containing Protein 4 Market Future Investment and Forecast 2029 | Aptose Biosciences Inc and Arvinas IncBromodomain Containing Protein 4 Market Future Investment and Forecast 2029 | Aptose Biosciences Inc and Arvinas Inc
www.marketwatch.com - March 23 at 9:34 AM
Aptose Biosciences (NASDAQ:APTO) Posts  Earnings Results, Beats Estimates By $0.01 EPSAptose Biosciences (NASDAQ:APTO) Posts Earnings Results, Beats Estimates By $0.01 EPS
www.americanbankingnews.com - March 11 at 8:43 AM
BRIEF-Aptose Posts Quarterly Net Loss Of $7.7 MillionBRIEF-Aptose Posts Quarterly Net Loss Of $7.7 Million
www.reuters.com - March 10 at 6:44 PM
Aptose Biosciences, Inc. to Host Earnings CallAptose Biosciences, Inc. to Host Earnings Call
finance.yahoo.com - March 10 at 6:44 PM
Aptose Reports Results for the Fourth Quarter and Full Year 2019Aptose Reports Results for the Fourth Quarter and Full Year 2019
finance.yahoo.com - March 10 at 6:44 PM
Aptose to Release Fourth Quarter and Year End December 31, 2019 Financial Results and Hold Conference Call on March 10, 2020Aptose to Release Fourth Quarter and Year End December 31, 2019 Financial Results and Hold Conference Call on March 10, 2020
www.benzinga.com - February 25 at 7:42 AM
Could This Cancer Drug Developer’s Stock Make You Rich?Could This Cancer Drug Developer’s Stock Make You Rich?
www.fool.com - February 14 at 1:18 PM
Aptose Biosciences, Inc. Common Shares (APTO) Pre-Market QuotesAptose Biosciences, Inc. Common Shares (APTO) Pre-Market Quotes
www.nasdaq.com - February 12 at 6:26 PM
Stock To Watch: Aptose Biosciences (APTO) Stock To Watch: Aptose Biosciences (APTO)
www.rttnews.com - February 12 at 4:34 AM
Aptose Biosciences (APTO) Presents At Key Opinion Leader Symposium: CG-806 for AML - SlideshowAptose Biosciences (APTO) Presents At Key Opinion Leader Symposium: CG-806 for AML - Slideshow
seekingalpha.com - February 11 at 1:56 PM
Aptose Biosciences to Host Key Opinion Leader Event Present at BIO CEO & Investor ConferenceAptose Biosciences to Host Key Opinion Leader Event Present at BIO CEO & Investor Conference
feeds.benzinga.com - January 29 at 7:48 AM
Is the Options Market Predicting a Spike in Aptose (APTO) Stock?Is the Options Market Predicting a Spike in Aptose (APTO) Stock?
finance.yahoo.com - January 17 at 2:18 PM
Aptose Biosciences (APTO) Presents At Biotech Showcase 2020 - SlideshowAptose Biosciences (APTO) Presents At Biotech Showcase 2020 - Slideshow
seekingalpha.com - January 14 at 8:38 PM
Hedge Funds Have Never Been This Bullish On Aptose Biosciences Inc (APTO)Hedge Funds Have Never Been This Bullish On Aptose Biosciences Inc (APTO)
finance.yahoo.com - December 19 at 10:54 PM
Aptose Gains on OfferingAptose Gains on Offering
www.baystreet.ca - December 17 at 11:15 PM
Aptose up 3% after pricing stock offeringAptose up 3% after pricing stock offering
seekingalpha.com - December 17 at 12:51 PM
Aptose Bio launches equity offering; shares down 13% after hoursAptose Bio launches equity offering; shares down 13% after hours
seekingalpha.com - December 16 at 7:27 PM
Why Aptose Biosciences Shares Jumped TodayWhy Aptose Biosciences Shares Jumped Today
www.fool.com - December 11 at 7:05 PM
BRIEF-Aptose Presents New Preclinical Cg-806 Data At The 2019 Ash Annual MeetingBRIEF-Aptose Presents New Preclinical Cg-806 Data At The 2019 Ash Annual Meeting
www.msn.com - December 10 at 12:11 AM
Aptose up 38% on encouraging CG-806 dataAptose up 38% on encouraging CG-806 data
seekingalpha.com - December 9 at 2:11 PM
Aptose Presents Highlights From Corporate Event At ASHAptose Presents Highlights From Corporate Event At ASH
finance.yahoo.com - December 7 at 11:55 AM
Diffuse Large B Cell Lymphoma Drug Market Analysis 2019-2026| AbbVie, Arrien Pharmaceuticals,Aptose BiosciencesDiffuse Large B Cell Lymphoma Drug Market Analysis 2019-2026| AbbVie, Arrien Pharmaceuticals,Aptose Biosciences
www.marketwatch.com - November 25 at 9:25 AM
Is Aptose Biosciences (TSE:APS) In A Good Position To Deliver On Growth Plans?Is Aptose Biosciences (TSE:APS) In A Good Position To Deliver On Growth Plans?
finance.yahoo.com - November 11 at 9:03 AM
Aptose Biosciences EPS beats by $0.01Aptose Biosciences EPS beats by $0.01
seekingalpha.com - November 5 at 7:02 PM
Aptose Reports Results for the Third Quarter Ended September 30, 2019Aptose Reports Results for the Third Quarter Ended September 30, 2019
finance.yahoo.com - November 5 at 7:02 PM
Aptose To Release Third Quarter Ended September 30, 2019 Financial Results and Hold Conference Call on November 5, 2019Aptose To Release Third Quarter Ended September 30, 2019 Financial Results and Hold Conference Call on November 5, 2019
finance.yahoo.com - October 22 at 7:30 AM
Aptose to Participate at 5th International Conference on Acute Myeloid Leukemia of the European School of Haematology (ESH)Aptose to Participate at 5th International Conference on Acute Myeloid Leukemia of the European School of Haematology (ESH)
finance.yahoo.com - October 10 at 8:02 AM
Bromodomain Containing Protein 4 Market By Current Industry Status,Growth Opportunities, Top Key Players, Target Audience And Forecast To 2022Bromodomain Containing Protein 4 Market By Current Industry Status,Growth Opportunities, Top Key Players, Target Audience And Forecast To 2022
www.marketwatch.com - September 21 at 5:52 PM
Global Caspase 3 Market Analysis 2019- Aptose Biosciences Inc, BeyondSpring Pharmaceuticals Inc, Conatus Pharmaceuticals IncGlobal Caspase 3 Market Analysis 2019- Aptose Biosciences Inc, BeyondSpring Pharmaceuticals Inc, Conatus Pharmaceuticals Inc
www.marketwatch.com - August 15 at 8:15 AM
Aptose Biosciences to Present at Canaccord Genuity 39th Annual Growth ConferenceAptose Biosciences to Present at Canaccord Genuity 39th Annual Growth Conference
finance.yahoo.com - July 30 at 8:04 AM
Aptose To Release Second Quarter Ended June 30, 2019 Financial Results and Hold Conference Call on August 6, 2019Aptose To Release Second Quarter Ended June 30, 2019 Financial Results and Hold Conference Call on August 6, 2019
finance.yahoo.com - July 23 at 8:03 AM
Aptose Doses First CLL Patient in Phase 1 Study of CG-806 and Doses Third Cohort in Phase 1 Study of APTO-253Aptose Doses First CLL Patient in Phase 1 Study of CG-806 and Doses Third Cohort in Phase 1 Study of APTO-253
finance.yahoo.com - July 16 at 8:04 AM
Aptose Presents New Preclinical Data for CG-806 at the 24th Congress of the European Hematology AssociationAptose Presents New Preclinical Data for CG-806 at the 24th Congress of the European Hematology Association
finance.yahoo.com - June 14 at 8:02 AM
Aptose Biosciences Announces Results of Annual and Special Meeting of ShareholdersAptose Biosciences Announces Results of Annual and Special Meeting of Shareholders
finance.yahoo.com - June 4 at 5:39 PM
Aptose Appoints Jotin Marango, M.D., Ph.D. as Chief Business OfficerAptose Appoints Jotin Marango, M.D., Ph.D. as Chief Business Officer
finance.yahoo.com - June 3 at 5:43 PM
Aptose Drifting Ahead Of Real Data From Its Intriguing Clinical AssetsAptose Drifting Ahead Of Real Data From Its Intriguing Clinical Assets
seekingalpha.com - June 1 at 10:02 AM
Aptose prices stock offering, shares down 18% premarketAptose prices stock offering, shares down 18% premarket
seekingalpha.com - May 30 at 5:52 PM
Aptose Announces Pricing of Public Offering of Common SharesAptose Announces Pricing of Public Offering of Common Shares
finance.yahoo.com - May 30 at 5:52 PM
Aptose readies stock offering; shares down 12% after hoursAptose readies stock offering; shares down 12% after hours
seekingalpha.com - May 29 at 7:15 PM
Global Diffuse Large B Cell Lymphoma Drug Market 2018- AbbVie, Arrien Pharmaceuticals, Aptose BiosciencesGlobal Diffuse Large B Cell Lymphoma Drug Market 2018- AbbVie, Arrien Pharmaceuticals, Aptose Biosciences
www.marketwatch.com - May 6 at 8:44 AM
Aptose Presents New Preclinical Data on CG-806 and APTO-253 at the 2019 AACR Annual MeetingAptose Presents New Preclinical Data on CG-806 and APTO-253 at the 2019 AACR Annual Meeting
www.nasdaq.com - April 1 at 5:24 PM
Aptose Biosciences Inc. (TSE:APS): Set To Experience A Decrease In Earnings?Aptose Biosciences Inc. (TSE:APS): Set To Experience A Decrease In Earnings?
finance.yahoo.com - March 27 at 5:43 PM
FDA accepts Aptoses IND for CG-806; shares up 10% premarketFDA accepts Aptose's IND for CG-806; shares up 10% premarket
seekingalpha.com - March 25 at 10:14 AM
Aptose Announces FDA Allowance of Investigational New Drug Application for CG-806Aptose Announces FDA Allowance of Investigational New Drug Application for CG-806
finance.yahoo.com - March 25 at 10:14 AM
Aptose Biosciences Inc. (APTO) CEO William Rice on Q4 2018 Results - Earnings Call TranscriptAptose Biosciences Inc. (APTO) CEO William Rice on Q4 2018 Results - Earnings Call Transcript
seekingalpha.com - March 13 at 9:27 AM
Aptose Biosciences, Inc. (APTO) After Hours TradingAptose Biosciences, Inc. (APTO) After Hours Trading
www.nasdaq.com - March 12 at 4:43 PM
This page was last updated on 4/4/2020 by MarketBeat.com Staff

Featured Article: What is a Swap?

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel